Table 1.
Characteristics of transplant recipients with COVID-19 in the included case reports
| Reference | Country | No | Organ | Median age | Mild/Asympt-omatic | Moderate | Severe | Sex | Alive |
|---|---|---|---|---|---|---|---|---|---|
| Mathies et al [6] | Germany | 1 | Heart | 77 | 1 | M | 1 (100%) | ||
| Chen et al [7] | China | 1 | Kidney | 49 | 1 | M | 1 (100%) | ||
| Arpali et al [8] | Turkey | 1 | Kidney | 28 | 1 | F | 1 (100%) | ||
| Guillen at el [2] | Spain | 1 | Kidney | 50 | 1 | M | 1 (100%) | ||
| Zhong et al [9] | China | 2 | 1 Kidney 1 liver |
48, 37 | 1 | 1 | 2M | 2 (100%) | |
| Zhu et al [10] | China | 10 | Kidney | 44.5 | 2 | 8 | 8M/2F | 9 (90%) | |
| Akalin et al [11] | USA | 36 | Kidney | 60 | 8 | 17 | 11 | 26M/ 10F | 26 (72%) |
| Lagana et al [12] | USA | 1 | Liver | 1 | 1 | F | 1 (100%) | ||
| Hsu et al [13] | USA | 1 | Heart/ Kidney | 39 | 1 | M | 1 (100%) | ||
| Wang et al [14] | China | 1 | Kidney | 49 | 1 | M | 1 (100%) | ||
| D’Antiga [15] | Italy | 3 | Liver | pediatric | 3 | 3 (100%) | |||
| Donato et al [16] | Italy | 8 | Liver | 70 | 6 | 2 | 6M/2F | 8 (100%) | |
| Marx et al [17] | Italy | 1 | Kidney | 58 | 1 | M | 1 (100%) | ||
| Huang et al [18] | China | 1 | Liver | 59 | 1 | M | 0 | ||
| TCUKTP [19] | USA | 15 | Kidney | 51 | 5 | 6 | 4 | 10M/ 5F | 13 (86%) |
| Kates et al [20] | USA | 4 | 1 Kidney 1 Liver 1 Heart 1 Lung |
62.5 | 2 | 1 | 1 | 3M/1F | 4 (100%) |
| Fontana et al [21] | Italy | 1 | Kidney | 61 | 1 | M | 1 (100%) | ||
| Periera et al [22] | USA | 90 | 46 Kidney 13 Liver 9 Heart 17 Lung 5 Dual |
57 | 22 | 41 | 27 | 53 M/ 37 F | 74 (82%) |
| Fernandez-Ruiz et al [23] | Spain | 18 | 8 Kidney 6 Liver 4 Heart |
71 | 5 | 8 | 5 | 13M/ 5F | 13 (72%)* |
| Huang et al [24] | China | 2 | 1 Kidney 1 HSCT |
55 | 2 | 2M | 0 | ||
| Bhoori et al [25] | Italy | 3** | Liver | >65*** | 3 | 3M | 0 | ||
| Chen et al [26] | China | 3 | Lung╪ | 66 | 3 | 3M | 2 (66%) | ||
| Alberici et al [27 | Italy | 20 | Kidney | 59 | 11 | 9 | 16M/ 4F | 15 (75%) | |
| Ning et al [28] | China | 1 | Kidney | 29 | 1 | M | 1 (100%) | ||
| Qin et al [29] | China | 1 | Liver | 37 | 1 | M | 1 (100%) | ||
| Seminari et al [30] | Italy | 1 | Kidney | 50 | 1 | M | 1 (100%) | ||
| Zhu et al [31] | China | 1 | Kidney | 52 | 1 | M | 1 (100%) | ||
| Liu et al [32] | China | 1 | Liver | 50 | 1 | M | 1 (100%) | ||
| Maggi et al [33] | Italy | 2 | Liver | 61, 69 | 2M | 1 (50%) | |||
| Bartiromo et al [34] | Italy | 1 | Kidney | 36 | 1 | F | 1 (100%) | ||
| Zhang et al [35] | China | 5 | Kidney | 45 | 5 | 4M/1F | 5 (100%) | ||
| Li et al [36] | China | 2 | Heart | 51, 43 | 1 | 1 | 2M | 2 (100%) | |
| Gandolfini et al [37] | Italy | 2 | Kidney | 75, 52 | 2 | 1M/1F | 1 (50%) | ||
| Banerjee et al [38] | UK | 7 | Kidney | 54 | 2 | 5 | 4M/3F | 6 (85%) | |
| Kim et al [39] | Korea | 2 | Kidney | 56, 36 | 2 | 2M | 2 (100%) | ||
| Nair et al [40] | USA | 10 | Kidney | 57 | 3 | 2 | 5 | 6M/4F | 7 (70%) |
| Meziyerh et al [41] | Nether-lands | 1 | Kidney | 35 | 1 | M | 1 (100%) | ||
| Hammami et al [42] | USA | 1 | Liver | 63 | 1 | M | 1 (100%) | ||
| Aigner et al [43] | Germany | 1 | Lung | 59 | 1 | F | 1 (100%) | ||
| Billah et al [44] | USA | 1 | Kidney | 44 | 1 | M | 1 (100%) | ||
| Machado et al [45] | Brazil | 1 | Kidney/ Liver | 69 | 1 | M | 1 (100%) | ||
| Bussalino et al [46] | Italy | 1 | Kidney | 32 | 1 | M | 1 (100%) | ||
| Abrishami et al [47] | Iran | 12 | Kidney | 47 | 12 | 9M/ 3F | 4 (25%) | ||
| Malard et al [48] | France | 7 | HSCT | 61 | 4 | 3 | 5M/2F | 6 (86%) | |
| Montagud-Marrahi et al [49] | Spain | 33 | 31 Kidney 2 Dual |
57 | 7 | 13 | 13 | 19M/14F | 31 (94%) |
| Holzhauser et al [50] | USA | 2 | Heart | 67 | 2 | M/F | 1 (50%) |
*Mortality 2 Kidney, 2 Lung, 1 Heart
**148 patient data was not available (only report 3 male patients were reported)
*** This was the age reported
╪ Patients received lung transplants for COVID-19
F: Female; M: Male; NA, not available; TCUKTP: The Columbia University Kidney Transplant Program